Finzala

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 31, 2023
Approval ID: 39685618-1921-4720-9c00-5ca8fb10a815
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FINZALA safely and effectively. See full prescribing information for FINZALA. FINZALA (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets), for oral use Initial U.S. Approval: 1968

Quick Stats

Total Products1

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.